𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Maternal asthma, asthma medication use, and the risk of congenital heart defects

✍ Scribed by Shao Lin; Michele Herdt-Losavio; Lenore Gensburg; Elizabeth Marshall; Charlotte Druschel


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
90 KB
Volume
85
Category
Article
ISSN
1542-0752

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND: Asthma is a common problem that complicates pregnancy. Several drugs are considered acceptable for use during pregnancy, although none have been classified as safe. Few studies have assessed the health impact of maternal asthma/medication use on the fetus. METHODS: A population‐based case‐control study was conducted in New York State to determine if cardiac congenital malformations in offspring were associated with maternal use of asthma medication and/or maternal asthma. Cases were cardiac anomalies in the New York State Congenital Malformations Registry. Controls were live births without any major birth defects randomly selected from birth certificates and frequency matched by year of birth. Data were collected through a 30 min telephone interview. Exposure was maternal asthma/medication use, maternal asthma/no medication use, no asthma/medication use, and no asthma/no medication use (reference). RESULTS: A total of 502 (59.4%) cases and 1,066 (53.8%) controls participated. A positive association was seen between any heart defect and women with asthma who used medication (OR 2.38; 95% CI: 1.18, 4.82). No significant associations were observed between heart defects and either women with asthma who did not use medication or women without asthma who used asthma medications. When considering types of medication used, offspring of women with asthma who used bronchodilators had an increased risk of any heart defect (OR 2.20; 95%CI: 1.05, 4.61). CONCLUSIONS: These results suggest that both maternal asthma status (controlled vs. uncontrolled; severe vs. mild) and asthma medication use, particularly bronchodilators, may play a role in cardiac malformations in offspring. Birth Defects Research (Part A), 2009. Β© 2008 Wiley‐Liss, Inc.


πŸ“œ SIMILAR VOLUMES


Maternal febrile illnesses, medication u
✍ Karon Abe; Margaret A. Honein; Cynthia A. Moore πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 1 views

## Abstract ## BACKGROUND Renal anomalies occur in about three infants per 1000 live births and have been associated with several environmental risk factors. Researchers have yet to assess the effect of maternal febrile illnesses on renal anomalies, even though febrile illnesses have been associat

Effect of maternal asthma on the risk of
✍ Lucie Blais; Fatima-Zohra Kettani; Naoual Elftouh; AmΓ©lie Forget πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 100 KB πŸ‘ 1 views

## Abstract ## BACKGROUND There is a lack of consensus in the literature about the effect of maternal asthma on the development of congenital malformations. ## OBJECTIVE To further examine the association between maternal asthma and the risk of congenital malformations. ## METHODS A cohort of

Maternal hypertension, antihypertensive
✍ Alissa R. Caton; Erin M. Bell; Charlotte M. Druschel; Martha M. Werler; Allen A. πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 86 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: Hypertensive disorders occur in an estimated 5–10% of pregnancies, but few studies have examined birth defects in relation to high blood pressure and antihypertensive medication use. The objective of this study was to investigate the relationship between high blood press

Selection of controls in case-control st
✍ Marian K. Bakker; Hermien E.K. de Walle; Aileen Dequito; Paul B. van den Berg; L πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 74 KB πŸ‘ 1 views

## Abstract ## BACKGROUND: In case‐control studies on teratogenic risks of maternal drug use during pregnancy, the use of normal or malformed controls may lead to recall‐bias or selection bias. This can be avoided by using controls with a genetic disorder. However, researchers are hesitant to use